CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 4 Grant or award Director acquired 1,209 shares (grant or award)
- 4 Open-market sale CLO & Secretary sold 1,000 shares at $104.00 ($104,000)
- 4 Exercise or conversion Director acquired 2,406 shares (option exercise)
- 4 Open-market buy Chief Executive Officer bought 9,510 shares at an average $105.20 ($1,000,456)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at an average $104.06 ($156,090)
- 4 Exercise or conversion Director acquired 2,406 shares (option exercise)
- 4 Grant or award CLO & Secretary acquired 6,415 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at $115.03 ($575,149)
- 4 Grant or award Chief Executive Officer acquired 21,382 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 13,452 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 9,587 shares (to pay taxes)
- 4 Shares withheld for taxes CLO & Secretary gave up 6,523 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 2,104 shares at $116.37 ($244,850)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,859 shares (to pay taxes)
- 4 Open-market sale Director sold 2,406 shares at $123.65 ($297,502)
- 4 Open-market sale CLO & Secretary sold 2,000 shares at $99.60 ($199,201)
- 4 Open-market sale Chief Financial Officer sold 1,275 shares at an average $103.94 ($132,518)
- 4 Open-market sale President & COO sold 16,047 shares at an average $102.35 ($1,642,359)
- 4 Exercise or conversion Chief Financial Officer acquired 1,486 shares (option exercise)
- 4 Exercise or conversion President & COO acquired 5,774 shares (option exercise)
Page 5 of 51 · 1,001 filings